Gilead's Pharma Launch Strategy: Patient-First Approach

Imagine a doctor trying to help people with lung cancer.

Varun Sharma at Gilead Sciences figures out the best way to launch new medicines.

He listens to patients, doctors, and nurses (primary research), and then checks what actually happens with the data (secondary data).

He sees how patients' needs change.

He uses this to create plans that focus on what patients really want, like feeling better and having a good life.

This helps Gilead make better decisions about their medicines and how they can help people who need them, by understanding what the patients and doctors actually do.